While the tumor cells in our previous study of EBV+ PTCL were of the CD4+CD8-CD56- phenotype, we found that various proportions of EBER+ cells were of the null type (CD45RO-CD3-CD4-, also CD20-) [35]. This evidence concerns the gene CD8A and neoplasm.